Blog

Sharing Our Expertise

Confronting Drug Supply Chain Risks
The current coronavirus epidemic and subsequent shutdown of travel to and from affected areas in China...
Read More >
How to Select the Right Pharmaceutical Sourcing Model
Farewell to the Blockbuster? The blockbuster drug era is widely reported to be coming to an end. Last...
Read More >
Top 2020 Pharma Supply Chain Logistics Trends
In previous posts, (here and here) we’ve discussed the growing scrutiny on bio/pharmaceutical supply...
Read More >
How to Stay Compliant in a Changing Pharma Regulatory Landscape
In 2012, contaminated medications from the New England Compounding Center (NECC) caused a meningitis...
Read More >
Understanding 505(b)(2) Drug Development & API Supply Issues
Situated between the NDA and the ANDA is an increasingly popular drug commercialization pathway – the...
Read More >
Behind the Scenes with LGM Pharma’s API Sourcing Team
Running a marathon is just like what we do here at LGM Pharma – and in more ways than one, as it turns...
Read More >